Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Optimizing Oral Therapy in Kidney Cancer
Renal cell carcinoma (RCC) continues to have a significant health impact. With the emergence of these new therapies, it is increasingly important for oncology nurses to understand the data supporting all the available choices and the adverse effects associated with each of them.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Renal Cell Carcinoma
Management of Renal Cell Carcinoma (RCC)
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Management of Metastatic Kidney Cancer
Despite significant improvements in response and survival with first-line therapies, progression is universal in patients with metastatic renal cell carcinoma (RCC) requiring second, third, fourth, or further lines of therapy.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Biomarker Testing for Immunotherapy
Recommendations and requirements for biomarker testing vary by the type of immune checkpoint inhibitor (ICI), specific tumor characteristics, and treatment setting.
Category
  • Bladder Cancer
  • Colorectal Cancer
  • Gynecologic Cancers
  • Kidney Cancer
  • Lung Cancers
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation